vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
21.03
-0.71 (-3.27%)
Nov 6, 2026, 4:00 PM EST - Market closed

vTv Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26149691235467
Market Cap Growth
36.30%445.89%288.02%-56.62%-18.92%-32.00%
Enterprise Value
18439852276493
Last Close Price
21.0339.9913.8111.5026.5139.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.09-89.38-26.7616.63
PB Ratio
3.757.706.36-1.269.254.38
P/TBV Ratio
3.757.707.45---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.00-51.49-31.6923.20

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.01-0.030.120.06
Net Debt / Equity Ratio
-1.11-1.38-2.560.48-1.96-0.83
Net Debt / EBITDA Ratio
7.032.711.520.350.510.63
Net Debt / FCF Ratio
-3.521.450.470.710.65
Asset Turnover
0.41-0.04-0.070.20
Quick Ratio
10.9913.397.070.911.601.61
Current Ratio
11.1913.547.341.003.521.84
Return on Equity (ROE)
-10.95%-78.94%---238.10%-186.50%
Return on Assets (ROA)
-7.70%-32.00%-61.33%-72.03%-47.99%-62.28%
Return on Capital Employed (ROCE)
-15.30%-39.40%-73.10%-6391.50%-88.30%-118.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.94%-5.44%-20.31%-86.44%-35.48%-19.50%
FCF Yield
-6.42%-5.09%-27.84%-81.45%-29.70%-28.99%
Buyback Yield / Dilution
-78.56%-45.96%-176.79%-8.60%-22.58%-32.90%
SEC Filings: 10-K · 10-Q